Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentabio Vaccine Booster Study in Children
NCT02095314Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Mar 2014
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Pentabio in diphtheria, Tetanus, pertussis and 2 more, sponsored by Bio Farma. Primary endpoint: Geometric Mean Titer. Started Mar 2014; status: completed.
02
Drugs
Pentabio
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT02095314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095314.